Clinical Trial Update: Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of the XELOX regimen (capecitabine plus oxaliplatin) in patients with potentially resectable liver met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Potentially Resectable Liver Metastasis From CRC, Colorectal Cancer | Phase 2 | Status: UNKNOWN